Table 4

Multivariate analysis (Cox regression) for the OS in AML patients with intermediate-risk karyotype (N = 171)

VariableHazard ratio95% CIP
Age* 1.692 0.967-2.961 .065 
WBC 2.216 1.296-3.787 .004 
NPM1+/FLT-ITD 0.335 0.140-0.798 .014 
CEBPAdouble 0.285 0.119-0.685 .005 
TET2 1.804 0.934-3.484 .079 
VariableHazard ratio95% CIP
Age* 1.692 0.967-2.961 .065 
WBC 2.216 1.296-3.787 .004 
NPM1+/FLT-ITD 0.335 0.140-0.798 .014 
CEBPAdouble 0.285 0.119-0.685 .005 
TET2 1.804 0.934-3.484 .079 
*

Age older than 60 years versus age 60 years or younger.

WBC > 50 × 103/μL versus ≤ 50 × 103/μL.

or Create an Account

Close Modal
Close Modal